Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
September 30, 2018 96.80%
June 30, 2018
March 31, 2018
December 31, 2017 0.00%
September 30, 2017
June 30, 2017
March 31, 2017
December 31, 2016 0.00%
September 30, 2016
June 30, 2016 0.00%
March 31, 2016
December 31, 2015 0.00%
September 30, 2015
June 30, 2015
March 31, 2015
December 31, 2014 0.00%
September 30, 2014
June 30, 2014
March 31, 2014
December 31, 2013 0.00%
September 30, 2013
June 30, 2013 0.00%
March 31, 2013
December 31, 2012 73.30%
September 30, 2012
Date Value
June 30, 2012
March 31, 2012
December 31, 2011 75.00%
September 30, 2011
June 30, 2011 84.60%
March 31, 2011
December 31, 2010 0.00%
September 30, 2010
June 30, 2010
March 31, 2010
December 31, 2009 0.00%
September 30, 2009 0.00%
June 30, 2009 0.00%
March 31, 2009 0.00%
December 31, 2008 87.20%
September 30, 2008 0.00%
June 30, 2008 0.00%
March 31, 2008 0.00%
December 31, 2007 93.46%
September 30, 2007 0.00%
June 30, 2007 0.00%
March 31, 2007 0.00%
December 31, 2006 0.00%
September 30, 2006 0.00%
June 30, 2006

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Agenus, Inc. 98.50%
Amgen, Inc. 72.08%
Anika Therapeutics, Inc. 65.15%
BioCryst Pharmaceuticals, Inc. 98.01%
Imunon, Inc. --